Abdelsalam Mahmoud, Ross Laura, Sughayar Rana, MacPherson Alexander, Bharadwaj Lalita, Canales Donaldo D, Chute Ian C, Avileli Mrudula, O'Brien Pierre, Salem Maged, Abdel-Samad Nizar
The Moncton Hospital, Horizon Health Network, Moncton, New Brunswick, Canada.
Dalhousie Medicine New Brunswick, Saint John, New Brunswick, Canada.
J Patient Exp. 2025 Jul 21;12:23743735251360831. doi: 10.1177/23743735251360831. eCollection 2025.
The present study assessed the impact of the COVID-19 pandemic on adult oncology patients at an oncology clinic in Atlantic Canada. Patients completed a survey about their cancer diagnosis, treatment, and the impact of the COVID-19 pandemic on their health between September 2021 and April 2022. Seroprotection from the COVID-19 vaccine was assessed in a subset of patients. Of the 178 patients who provided consent, 161 completed the survey and 134 provided blood samples for seropositive analysis. Most reported no perceived delays in their cancer diagnosis (93.2%), treatment (91.8%), or follow-up care (98.1%) because of the pandemic. Although 75.2% of patients reported anxiety about contracting COVID-19, majority (96.3%) did not miss their appointments because of the pandemic. Seroprotection rates after COVID-19 vaccination did not differ significantly by treatment type; however, patients with hematological cancers had a significantly lower response. This study offers a snapshot of how the COVID-19 pandemic affected the diagnosis, treatment, and well-being of patients with cancer. The findings may help to guide clinical decisions and mitigate care delays in the future.
本研究评估了新冠肺炎疫情对加拿大大西洋地区一家肿瘤诊所成年肿瘤患者的影响。患者在2021年9月至2022年4月期间完成了一项关于其癌症诊断、治疗以及新冠肺炎疫情对其健康影响的调查。在一部分患者中评估了新冠肺炎疫苗的血清保护情况。在178名提供同意的患者中，161名完成了调查，134名提供了血样进行血清阳性分析。大多数患者报告称，由于疫情，他们在癌症诊断（93.2%）、治疗（91.8%）或后续护理（98.1%）方面没有感觉到延迟。尽管75.2%的患者报告担心感染新冠肺炎，但大多数患者（96.3%）并没有因为疫情而错过预约。新冠肺炎疫苗接种后的血清保护率在不同治疗类型之间没有显著差异；然而，血液系统癌症患者的反应明显较低。本研究提供了一幅新冠肺炎疫情如何影响癌症患者诊断、治疗和健康状况的快照。这些发现可能有助于指导未来的临床决策并减少护理延误。
